Author

Sadhna Dhingra

Houston MethodistORCID 0000-0003-0436-033XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Arvind BhimarajiD· 1 shared Muthu Kumar KrishnamoorthiiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

2 top collaborators · 1 mutual co-author link

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Arvind BhimarajORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BioengineeringbioRxivPreprintMay 26, 2026

A novel mRNA Lipid Nanoparticle Therapy Improves Heart Failure Phenotype and Suppresses Endothelial-Mesenchymal Transition In Vitro

Muthu Kumar Krishnamoorthi, Sadhna Dhingra, Arvind Bhimaraj

This paper evaluates a BMP-7 mRNA-lipid nanoparticle therapy for heart failure, showing improved cardiac function and reduced fibrosis in mice, along with suppression of endothelial-to-mesenchymal transition in vitro.

DOI 10.64898/2026.05.22.727265

mousebulk RNA-seq

𝕏 PostBluesky